← FDA Drug Approvals (Drugs@FDA)
IDELALISIB
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2026-02-17
Drug application
- FDA Application #
ANDA216921- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- IDELALISIB
- Generic name
- Idelalisib
- Active ingredients
- IDELALISIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- NATCO
- First approval
- 2026-02-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown